800 



-24- 



are so low in the U.S. that any risk of side effects would overwhelm potential 

 benefits. 



The reverse side of the coin is the stringent testing regulations in the 

 U.S. that have led some companies to test drugs for safety in other countries, 

 in effect using their people as guinea pigs for the American market. 



Neither situation is tenable. The answer must be found in some means of 

 Internationalizing drug evaluation since It would not be appropriate to expect 

 the FDA, for example, to institute its own criteria for evaluating drugs for 

 foreign applications that would be different from U.S.-appl ication criteria. 



Even if an international solution is needed, the general problem of 

 providing a means for greater commitment of U.S. scientific and technological 

 attention, whether in government, industry, or university, to 

 population-related issues will be and should be an important issue in the near 

 future. 



B. Transborder Issues 



A series of transborder and global science and technology issues will be 

 important elements of the international security picture in the next five 

 years, though the separation of these from "economic" issues is rather 

 arbitrary. The importance of environmental, ocean, resource and energy issues 

 will be largely in their economic and ultimately political effects, as is the 

 case for those just discussed. 



1 . Resources/Energy 



In the short-term, the major security-related issues arising in the 

 resoure/energy area have to do with supply interruption engendered by 



